EP 2647388 A1 20131009 - Antibodies Against ERBB3 and Uses Thereof

Title (en)

Antibodies Against ERBB3 and Uses Thereof

Title (de)

Antikörper gegen ERBB3 und Verwendungen davon

Title (fr)

Anticorps dirigés contre l'ERBB3 et leurs utilisations

Publication

EP 2647388 A1 20131009 (EN)

Application

EP 13174963 A 20080215

Priority

US 90190407 P 20070216
US 979608 P 20080102
EP 08725722 A 20080215

Abstract (en)

The invention provides an isolated monoclonal antibody or antigen binding portion thereof that binds to human ErbB3 and comprises: (a) a heavy chain variable region comprising the amino acid sequence of SEQ ID NO: 1 and a light chain variable region comprising the amino acid sequence of SEQ ID NO: 2; or (b) a heavy chain variable region comprising an amino acid sequence which is at least 80% identical to the amino acid sequence of SEQ ID NO: 1 and a light chain variable region comprising an amino acid sequence which is at least 80% identical to the amino acid sequence of SEQ ID NO: 2.

IPC 8 full level

A61K 39/395 (2006.01); A61P 35/00 (2006.01); A61K 33/243 (2019.01)

CPC (source: EP KR US)

A61K 9/0019 (2013.01 - US); A61K 31/337 (2013.01 - EP US); A61K 31/517 (2013.01 - EP US); A61K 39/395 (2013.01 - KR); A61K 39/3955 (2013.01 - US); A61K 39/39558 (2013.01 - EP US); A61P 1/00 (2017.12 - EP); A61P 11/00 (2017.12 - EP); A61P 13/08 (2017.12 - EP); A61P 13/12 (2017.12 - EP); A61P 15/00 (2017.12 - EP); A61P 17/00 (2017.12 - EP); A61P 35/00 (2017.12 - EP); A61P 43/00 (2017.12 - EP); C07K 16/28 (2013.01 - KR); C07K 16/2863 (2013.01 - EP US); C07K 16/32 (2013.01 - EP US); A61K 33/243 (2018.12 - EP US); A61K 2039/505 (2013.01 - EP US); C07K 2317/21 (2013.01 - EP US); C07K 2317/34 (2013.01 - US); C07K 2317/55 (2013.01 - EP US); C07K 2317/565 (2013.01 - US); C07K 2317/73 (2013.01 - EP US); C07K 2317/76 (2013.01 - EP US); C07K 2317/92 (2013.01 - EP US)

Citation (applicant)

US 5480968 A 19960102 - KRAUS MATTHIAS H [US], et al
US 4816567 A 19890328 - CABILLY SHMUEL [US], et al
US 5223409 A 19930629 - LADNER ROBERT C [US], et al
US 5403484 A 19950404 - LADNER ROBERT C [US], et al
US 5571698 A 19961105 - LADNER ROBERT C [US], et al
US 5427908 A 19950627 - DOWER WILLIAM J [US], et al
US 5580717 A 19961203 - DOWER WILLIAM J [US], et al
US 5969108 A 19991019 - MCCAFFERTY JOHN [GB], et al
US 6172197 B1 20010109 - MCCAFFERTY JOHN [GB], et al
US 5885793 A 19990323 - GRIFFITHS ANDREW DAVID [GB], et al
US 6521404 B1 20030218 - GRIFFITHS ANDREW DAVID [GB], et al
US 6544731 B1 20030408 - GRIFFITHS ANDREW DAVID [GB], et al
US 6555313 B1 20030429 - GRIFFITHS ANDREW DAVID [GB], et al
US 6582915 B1 20030624 - GRIFFITHS ANDREW DAVID [GB], et al
US 6593081 B1 20030715 - GRIFFITHS ANDREW DAVID [GB], et al
US 5545806 A 19960813 - LONBERG NILS [US], et al
US 5569825 A 19961029 - LONBERG NILS [US], et al
US 5625126 A 19970429 - LONBERG NILS [US], et al
US 5633425 A 19970527 - LONBERG NILS [US], et al
US 5789650 A 19980804 - LONBERG NILS [US], et al
US 5877397 A 19990302 - LONBERG NILS [US], et al
US 5661016 A 19970826 - LONBERG NILS [US], et al
US 5814318 A 19980929 - LONBERG NILS [US], et al
US 5874299 A 19990223 - LONBERG NILS [US], et al
US 5770429 A 19980623 - LONBERG NILS [US], et al
US 5545807 A 19960813 - SURANI AZIM M [GB], et al
WO 9203918 A1 19920319 - GENPHARM INT [US]
WO 9312227 A1 19930624 - GENPHARM INT [US]
WO 9425585 A1 19941110 - GENPHARM INT [US], et al
WO 9713852 A1 19970417 - GENPHARM INT [US], et al
WO 9824884 A1 19980611 - GENPHARM INT [US]
WO 9945962 A1 19990916 - GENPHARM INT [US], et al
WO 0114424 A2 20010301 - MEDAREX INC [US], et al
WO 0243478 A2 20020606 - MEDAREX INC [US], et al
US 5939598 A 19990817 - KUCHERLAPATI RAJU [US], et al
US 6075181 A 20000613 - KUCHERLAPATI RAJU [US], et al
US 6114598 A 20000905 - KUCHERLAPATI RAJU [US], et al
US 6150584 A 20001121 - KUCHERLAPATI RAJU [US], et al
US 6162963 A 20001219 - KUCHERLAPATI RAJU [US], et al
US 6040498 A 20000321 - STOMP ANNE-MARIE [US], et al
US 6815184 B2 20041109 - STOMP ANNE-MARIE [US], et al
WO 2005117973 A2 20051215 - MERRIMACK PHARMACEUTICALS INC [US], et al
WO 2006091209 A2 20060831 - MERRIMACK PHARMACEUTICALS INC [US], et al
WO 9411026 A2 19940526 - IDEC PHARMA CORP [US]
US 5399163 A 19950321 - PETERSON STEVEN F [US], et al
US 5383851 A 19950124 - MCKINNON JR CHARLES N [US], et al
US 5312335 A 19940517 - MCKINNON CHARLES M [US], et al
US 5064413 A 19911112 - MCKINNON CHARLES M [US], et al
US 4941880 A 19900717 - BURNS MARVIN [US]
US 4790824 A 19881213 - MORROW J THOMAS [US], et al
US 4596556 A 19860624 - MORROW J THOMAS [US], et al
US 4487603 A 19841211 - HARRIS DONALD L [US]
US 4486194 A 19841204 - FERRARA JAMES [US]
US 4447233 A 19840508 - MAYFIELD WILLIAM B [US]
US 4447224 A 19840508 - DECANT JR LEONARD J [US], et al
US 4439196 A 19840327 - HIGUCHI TAKERU [US]
US 4475196 A 19841002 - LA ZOR CLAIR G [US]
US 4522811 A 19850611 - EPPSTEIN DEBORAH A [US], et al
US 5374548 A 19941220 - CARAS INGRID W [US]
US 5399331 A 19950321 - LOUGHREY HELEN C [CA], et al
US 5416016 A 19950516 - LOW PHILIP S [US], et al
HYNES, BIOCHIM. BIOPHYS. ACTA REV. CANCER, vol. 1198, 1994, pages 165 - 184
KIM ET AL., BIOCHEM. J., vol. 334, 1998, pages 189 - 195
GUY ET AL., PROC. NATL. ACAD SCI. USA., vol. 91, 1994, pages 8132 - 8136
SIERKE ET AL., BIOCHEM. J., vol. 322, 1997, pages 757 - 763
KRAUS ET AL., PROC. NATL. ACAD SCI. USA., vol. 90, 1993, pages 2900 - 2904
SCHAEFER ET AL., NEOPLASIA, vol. 8, no. 7, 2006, pages 613 - 22
SCHAEFER ET AL., CANCER RES, vol. 64, no. 10, 2004, pages 3395 - 405
XUE ET AL., CANCER RES., vol. 66, 2006, pages 1418 - 1426
SLIWKOWSKI ET AL., J. BIOL. CHEM., vol. 269, no. 20, 1994, pages 14661 - 14665
PLOWMAN ET AL., PROC. NATL. ACAD SCI. USA, vol. 87, 1990, pages 4905 - 4909
KANI ET AL., BIOCHEMISTRY, vol. 44, 2005, pages 15842 - 857
CHO; LEAHY, SCIENCE, vol. 297, 2002, pages 1330 - 1333
KIM ET AL., BIOCHEM J., vol. 334, 1998, pages 189 - 195
SUDO; 2000 ET AL., METHODS ENZYMOT, vol. 322, no. 3, pages 88 - 92
MORGAN ET AL., EUR. J BIOCHEM., vol. 191, 1990, pages 761 - 767
WARD ET AL., NATURE, vol. 341, 1989, pages 544 - 546
BIRD ET AL., SCIENCE, vol. 242, 1988, pages 423 - 426
HUSTON ET AL., PROC. NATL. ACAD SCI. USA, vol. 85, 1988, pages 5879 - 5883
KOHLER ET AL., NATURE, vol. 256, 1975, pages 495
LONBERG ET AL., NATURE, vol. 368, no. 6474, 1994, pages 856 - 859
CLACKSON ET AL., NATURE, vol. 352, 1991, pages 624 - 628
MARKS ET AL., J MOL. BIOL., vol. 222, 1991, pages 581 - 597
KABAT ET AL.: "Sequences of proteins of Immunological Interest", 1991, N1H PUBLICATION NO. 91-3242
SONGSIVILAI; LACHMANN, CLIN. EXP. IMMUNOL., vol. 79, 1990, pages 315 - 321
KOSTELNY ET AL., J IMMUNOL., vol. 148, 1992, pages 1547 - 1553
"Epitope Mapping Protocols in Methods in Molecular Biology", vol. 66, 1996
STAHLI ET AL., METHODS IN ENZYMOLOGY, vol. 9, 1983, pages 242
KIRKLAND ET AL., J IMMUNOL., vol. 137, 1986, pages 3614
HARLOW; LANE: "Antibodies: A Laboratory Manual", 1988, COLD SPRING HARBOR PRESS
MOREL ET AL., MOT. IMMUNOL., vol. 25, no. 1, 1988, pages 7
CHEUNG ET AL., VIROLOGY, vol. 176, 1990, pages 546
MOLDENHAUER ET AL., SCAND J. IMMUNOL., vol. 32, 1990, pages 77
BRUMMELL ET AL., BIOCHEM., vol. 32, 1993, pages 1180 - 1187
KOBAYASHI ET AL., PROTEIN ENG., vol. 12, no. 10, 1999, pages 879 - 884
BURKS ET AL., PROC. NATT. ACAD SCI. USA, vol. 94, 1997, pages 412 - 417
E. MEYERS; W. MILLER, CABIOS, vol. 4, 1989, pages 11 - 17
NEEDLEMAN; WUNSCH, J. MOL. BIOL, 1970, pages 444 - 453
ALTSCHUL ET AL., J. MOL. BIOL., vol. 215, 1990, pages 403 - 10
ALTSCHUL ET AL., NUCLEIC ACIDS RES., vol. 25, no. 17, 1997, pages 3389 - 3402
"Current Protocols in Molecular Biology", 1987, GREENE PUBLISHING AND WILEY INTERSCIENCE
KOHLER; MILSTEIN, NATURE, vol. 256, 1975, pages 495
GODING: "Monoclonal Antibodies: Principles and Practice", 1986, ACADEMIC PRESS, pages: 59 - 103
GODING: "Monoclonal Antibodies:Principles and Practice", 1986, ACADEMIC PRESS, pages: 59 - 103
MCCAFFERTY ET AL., NATURE, vol. 348, 1990, pages 552 - 554
HOET ET AL., NATURE BIOTECHNOLOGY, vol. 23, 2005, pages 344 - 348
MARKS ET AL., BIOLTECHNOLOGY, vol. 10, 1992, pages 779 - 783
WATERHOUSE ET AL., NUC. ACIDS RES., vol. 21, 1993, pages 2265 - 2266
LONBERG, N., HANDBOOK OFEXPERIMENTAL PHARMACOLOGY, vol. 113, 1994, pages 49 - 101
LONBERG, N.; HUSZAR, D., INTERN. REV. IMMUNOL., vol. 13, 1995, pages 65 - 93
HARDING, F.; LONBERG, N., ANN. N.Y. ACAD SCI., vol. 764, 1995, pages 536 - 546
TOMIZUKA ET AL., PROC. NATL. ACAD SCI. USA, vol. 97, 2000, pages 722 - 727
KUROIWA ET AL., NATURE BIOTECHNOLOGY, vol. 20, 2002, pages 889 - 894
CRAMER ET AL., CURR. TOP. MICROBOL. 1MMUNOL, vol. 240, 1999, pages 95 - 118
HOOD ET AL., ADV. EXP. MED BIOL., vol. 464, 1999, pages 127 - 147
CONRAD ET AL., PTANTMOT. BIOL., vol. 38, 1998, pages 101 - 109
FISCHER ET AL., BIOTECHNOL. APPL. BIOCHEM., vol. 30, 1999, pages 99 - 108
MA ET AL., TRENDS BIOTECHNOL., vol. 13, 1995, pages 522 - 7
MA ET AL., PLANT PHYSIOL., vol. 109, 1995, pages 341 - 6
WHITELAM ET AL., BIOCHEM. SOC. TRANS., vol. 22, 1994, pages 940 - 944
MUNSON ET AL., ANAL. BIOCHEM., vol. 107, 1980, pages 220
RIECHMANN, L. ET AL., NATURE, vol. 332, 1998, pages 323 - 327
JONES, P. ET AL., NATURE, vol. 321, 1986, pages 522 - 525
QUEEN, C. ET AL., PROC. NATT. ACAD SEE. U.S.A., vol. 86, 1989, pages 10029 - 10033
HALL ET AL., J IMUNOL., vol. 149, 1992, pages 1605 - 1612
POLYMENIS ET AL., J. IMMUNOL., vol. 152, 1994, pages 5318 - 5329
JAHN ET AL., IMMUNOBIOL., vol. 193, 1995, pages 400 - 419
KLIMKA ET AL., BRIT. J CANCER, vol. 83, 2000, pages 252 - 260
BEIBOER ET AL., J MOL. BIOL, vol. 296, 2000, pages 833 - 849
RADER ET AL., PROC. NATL. ACAD SCI. USA, vol. 95, 1998, pages 8910 - 8915
BARBAS ET AL., J. AM. CHEM. SOC., vol. 116, 1994, pages 2161 - 2162
DITZEL ET AL., J. IMMUNOL., vol. 157, 1996, pages 739 - 749
CARON ET AL., J EXPMED., vol. 176, 1992, pages 1191 - 1195
SHOPES, B., J IMMUNOL., vol. 148, 1992, pages 2918 - 2922
WOLFF ET AL., CANCER RESEARCH, vol. 53, 1993, pages 2560 - 2565
STEVENSON ET AL., ANTI-CANCER DRUG DESIGN, vol. 3, 1989, pages 219 - 230
MILLSTEIN ET AL., NATURE, vol. 305, 1983, pages 537 - 539
SURESH ET AL., METHODS IN ENZYMOTOGY, vol. 121, 1986, pages 210
BRENNAN ET AL., SCIENCE, vol. 229, 1985, pages 81
KOSTELNY ET AL., J. IMMUNOL., vol. 148, no. 5, 1992, pages 1547 - 1.553
GRUBER ET AL., J IMMUNOL., vol. 152, 1994, pages 5368
VITETTA ET AL., SCIENCE, vol. 238, 1987, pages 1098
SUDO ET AL., METHODS ENZYMOL, vol. 322, 2000, pages 388 - 92
MORGAN ET AL., EUR. J. BIOCHEM., vol. 191, 1990, pages 761 - 767
WATERMAN ET AL., J. BIOL. CHEM., vol. 273, 1998, pages 13819 - 27
MACALLAN ET AL., PROC. NATL. ACAD SCI., vol. 95, no. 2, 20 December 1997 (1997-12-20), pages 708 - 13
PEREZ ET AL., CANCER RESEARCH, vol. 55, 1995, pages 392 - 398
HERMAN ET AL., JOURNAL OFBIOMOLECULAR SCREENING ELECTRONIC PUBLICATION, 2007
"Antibodies, A Laboratory Manual", 1988, COLD SPRING HARBOR LABORATORY
BERGE, S.M. ET AL., J PHARM. SCI., vol. 66, 1977, pages 1 - 19
"Sustained and Controlled Release Drug Delivery Systems", 1978, MARCEL DEKKER, INC.
STREJAN ET AL., J. NEUROIMMUNOL., vol. 7, 1984, pages 27
V.V. RANADE, J CLIN. PHARMACOL., vol. 29, 1989, pages 685
UMEZAWA ET AL., BIOCHEM. BIOPHYS. RES. COMMUN., vol. 153, 1988, pages 1038
P.G. BLOEMAN ET AL., FEBSLETT, vol. 357, 1995, pages 140
M. OWAIS ET AL., ANTIMICROB. AGENTS CHEMOTHER., vol. 39, 1995, pages 180
BRISCOE ET AL., AM. J. PHYSIOL., vol. 1233, 1995, pages 134
SCHREIER, J BIOL. CHEM., vol. 269, 1994, pages 9090
K. KEINANEN; M.L. LAUKKANEN, FEBS LETT., vol. 346, 1994, pages 123
J.J. KILLION; I.J. FIDLER, IMMUNOMETHODS, vol. 4, 1994, pages 273
SAMBROOK; FRITSCH; MANIATIS: "Molecular Cloning", 1989, COLD SPRING HARBOR LABORATORY PRESS
"Antibody Engineering Protocols", 1996, HUMANA PR, pages: 510
"Antibody Engineering: A Practical Approach", 1996, IRL PR
"Antibodies: A Laboratory Manual", 1999, C.S.H.L. PRESS
"Current Protocols in Molecular Biology", 1992, JOHN WILEY & SONS
CELL CULTURE MODELS AND ANIMAL MODELS OF VIRAL HEPATITIS. PART II: HEPATITIS C, LAB. ANIM. (NY)., vol. 34, no. 2, 2005, pages 39 - 47
"The chimpanzee model of hepatitis C virus infections", ILAR J., vol. 42, no. 2, 2001, pages 117 - 26
KOLB ET AL., INT. J. CANCER, vol. 120, 2006, pages 514 - 523
WASSAF ET AL., ANALYTICAL BIOCHEM., vol. 351, 2006, pages 241 - 253
BURTRUM ET AL., CANCER RES., vol. 63, 2003, pages 8912 - 8921
ADAMS ET AL., NATURE BIOTECHNOLOGY, vol. 23, 2005, pages 1147 - 1157
LEUNG ET AL., SCIENCE, vol. 246, no. 4935, 1989, pages 1306 - 9
YEN ET AL., ONCOGENE, vol. 19, no. 31, 2000, pages 3460 - 9
WALLENIUS ET AL., AM J PATHOL., vol. 156, no. 3, 2000, pages 821 - 9
ENGELMANN ET AL., SCIENCE, vol. 316, 2007, pages 1039 - 1043
GOU, PNAS, vol. 105, no. 2, 2007, pages 692 - 697

Citation (search report)

[A] EP 1283053 A1 20030212 - MAX PLANCK GESELLSCHAFT [DE]
[A] WO 2006091209 A2 20060831 - MERRIMACK PHARMACEUTICALS INC [US], et al
[A] WO 9735885 A1 19971002 - GENENTECH INC [US]
[A] LEE H ET AL: "ISOLATION AND CHARACTERIZATION OF FOUR ALTERNATE C-ERBB3 TRANSCRIPTS EXPRESSED IN OVARIAN CARCINOMA-DERIVED CELL LINES AND NORMAL HUMAN TISSUES", ONCOGENE, NATURE PUBLISHING GROUP, GB BASINGSTOKE, HANTS, vol. 16, no. 25, 25 June 1998 (1998-06-25), pages 3243 - 3252, XP001087557, ISSN: 0950-9232
[A] BALINT R F ET AL: "ANTIBODY ENGINEERING BY PARSIMONIOUS MUTAGENESIS", GENE, ELSEVIER, AMSTERDAM, NL, vol. 137, no. 1, 27 December 1993 (1993-12-27), pages 109 - 118, XP002031537, ISSN: 0378-1119
[A] MCKAY BROWN ET AL: "Tolerance to single, but not multiple, amino acid replacements in antibody V-H CDR2: A means of minimizing B cell wastage from somatic hypermutation?", THE JOURNAL OF IMMUNOLOGY, THE AMERICAN ASSOCIATION OF IMMUNOLOGISTS, US, vol. 156, no. 9, 1 January 1996 (1996-01-01), pages 3285 - 3291, XP002649029, ISSN: 0022-1767

Designated contracting state (EPC)

AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

Designated extension state (EPC)

AL BA MK RS

DOCDB simple family (publication)

WO 2008100624 A2 20080821; WO 2008100624 A3 20090115; AU 2008216600 A1 20080821; AU 2008216600 B2 20130905; BR PI0808055 A2 20130730; CA 2678181 A1 20080821; CA 2678181 C 20161213; CN 101674846 A 20100317; CN 101674846 B 20140702; CO 6231000 A2 20101220; CR 11029 A 20091229; CY 1114632 T1 20161005; DK 2129396 T3 20131125; DK 2716301 T3 20170731; EA 020465 B1 20141128; EA 200901119 A1 20101029; EC SP099637 A 20091228; EP 2129396 A2 20091209; EP 2129396 B1 20130821; EP 2647388 A1 20131009; EP 2716301 A2 20140409; EP 2716301 A3 20140716; EP 2716301 B1 20170405; EP 3248617 A2 20171129; EP 3248617 A3 20180221; ES 2431940 T3 20131128; ES 2631727 T3 20170904; HK 1138771 A1 20100903; HR P20131113 T1 20140117; HR P20170834 T1 20170825; HU E033472 T2 20171228; IL 200373 A0 20100429; IL 200373 A 20130930; JP 2010518820 A 20100603; JP 2014113167 A 20140626; JP 5564266 B2 20140730; KR 101598229 B1 20160226; KR 20100014426 A 20100210; MA 31254 B1 20100301; MX 2009008656 A 20091110; NZ 579644 A 20120525; PL 2129396 T3 20140228; PL 2716301 T3 20171031; PT 2129396 E 20131118; PT 2716301 T 20170704; RS 53042 B 20140430; SG 178789 A1 20120329; SI 2129396 T1 20131231; SI 2716301 T1 20170731; US 2009291085 A1 20091126; US 2010056761 A1 20100304; US 2010266584 A1 20101021; US 2011123523 A1 20110526; US 2014234329 A1 20140821; US 2017073427 A1 20170316; US 2019292271 A1 20190926; US 2022204642 A1 20220630; US 7846440 B2 20101207; US 8691225 B2 20140408; US 8961966 B2 20150224; US 9487588 B2 20161108; ZA 200906360 B 20140326

DOCDB simple family (application)

US 2008002119 W 20080215; AU 2008216600 A 20080215; BR PI0808055 A 20080215; CA 2678181 A 20080215; CN 200880009633 A 20080215; CO 09100503 A 20090916; CR 11029 A 20090916; CY 131101043 T 20131121; DK 08725722 T 20080215; DK 13180584 T 20080215; EA 200901119 A 20080215; EC SP099637 A 20090915; EP 08725722 A 20080215; EP 13174963 A 20080215; EP 13180584 A 20080215; EP 17150566 A 20080215; ES 08725722 T 20080215; ES 13180584 T 20080215; HK 10105467 A 20100602; HR P20131113 T 20131121; HR P20170834 T 20170531; HU E13180584 A 20080215; IL 20037309 A 20090813; JP 2009549644 A 20080215; JP 2014048517 A 20140312; KR 20097019335 A 20080215; MA 32222 A 20090915; MX 2009008656 A 20080215; NZ 57964408 A 20080215; PL 08725722 T 20080215; PL 13180584 T 20080215; PT 08725722 T 20080215; PT 13180584 T 20080215; RS P20130512 A 20080215; SG 2012010476 A 20080215; SI 200831098 T 20080215; SI 200831823 A 20080215; US 201414181334 A 20140214; US 201615274989 A 20160923; US 201816181054 A 20181105; US 202117376627 A 20210715; US 28192508 A 20080215; US 42587409 A 20090417; US 54527909 A 20090821; US 90449210 A 20101014; ZA 200906360 A 20090914